Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Flagship Ventures Fund Iv General Partner Llc


  • Large Shareholder, Director at Moderna Inc. (MRNA), 2019-12-12
  • Large Shareholder at Transmedics Group Inc. (TMDX), 2019-10-31
  • Large Shareholder at Axcella Health Inc. (AXLA), 2019-05-15
  • Large Shareholder, Director at Kaleido Biosciences Inc. (KLDO), 2019-03-06
  • Large Shareholder, Director at Rubius Therapeutics Inc. (RUBY), 2018-07-23
  • Large Shareholder at Evelo Biosciences Inc. (EVLO), 2018-05-16
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2017-08-21
  • Large Shareholder at Eleven Biotherapeutics Inc. (EBIO), 2016-09-26
  • Large Shareholder at Editas Medicine Inc. (EDIT), 2016-08-15
  • Large Shareholder at Seres Therapeutics Inc. (MCRB), 2016-05-27
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2014-08-14
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AXLA $20.00 500,000 Large Shareholder 986,023 2019-05-13 Filing
EVLO $16.00 281,250 Large Shareholder 18,233,403 2018-05-11 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MRNA $18.65 38,366 Large Shareholder, Director 8,190,766 2019-12-11 Filing
MRNA $18.65 199,935 Large Shareholder, Director 31,216,399 2019-12-11 Filing
MRNA $18.96 4,092 Large Shareholder, Director 8,229,132 2019-12-10 Filing
MRNA $18.96 21,325 Large Shareholder, Director 31,416,334 2019-12-10 Filing
MRNA $18.99 27,714 Large Shareholder, Director 8,233,224 2019-12-09 Filing